These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7403440)

  • 1. The interaction between adriamycin and radiation in a solid murine tumor.
    Siemann DW; Sutherland RM
    Radiat Res; 1980 Aug; 83(2):345-59. PubMed ID: 7403440
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular radiosensitivity and tumor radiation response in the EMT6 tumor cell system.
    Rockwell S; Kallman RF
    Radiat Res; 1973 Feb; 53(2):281-94. PubMed ID: 4695229
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxicity of aziridinylbenzoquinone for aerobic and hypoxic cells of a transplanted mouse mammary tumor and interaction of the drug with radiation and adriamycin.
    Tannock I
    Cancer Res; 1983 May; 43(5):2059-62. PubMed ID: 6831436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of a murine solid tumor to in vivo combined chemotherapy and irradiation.
    Wharam MD; Phillips TL; Kane L; Utley JF
    Radiology; 1973 Nov; 109(2):451-5. PubMed ID: 4126375
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL; Rauth AM; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adriamycin effects and the interactions of adriamycin with X irradiation on murine mammary tumors.
    Dethlefsen LA; Riley RM
    Radiat Res; 1982 Apr; 90(1):165-72. PubMed ID: 7063633
    [No Abstract]   [Full Text] [Related]  

  • 7. Repair of potentially lethal damage in vivo in solid tumor cells after x-irradiation.
    Hahn GM; Rockwell S; Kallman RF; Gordon LF; Frindel E
    Cancer Res; 1974 Feb; 34(2):351-4. PubMed ID: 4810908
    [No Abstract]   [Full Text] [Related]  

  • 8. 4'-Epi-doxorubicin and hyperthermia in a murine mammary carcinoma: influence of the dose and fractionation.
    Cividalli A; Danesi DT; Altavista P; Bonanni M; Persiani D; Segre L; Cruciani G
    Anticancer Res; 1995; 15(3):739-43. PubMed ID: 7645951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
    Plum SM; Hanson AD; Volker KM; Vu HA; Sim BK; Fogler WE; Fortier AH
    Clin Cancer Res; 2003 Oct; 9(12):4619-26. PubMed ID: 14555538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The response of viable tumor cords to a single dose of radiation.
    Tannock I; Howes A
    Radiat Res; 1973 Sep; 55(3):477-86. PubMed ID: 4743247
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of radiation response of a murine mammary carcinoma by two nitrofuran derivatives.
    Stone HB; Withers HR
    Radiat Res; 1975 Dec; 64(3):443-51. PubMed ID: 128031
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiosensitivity of lymph node metastases versus initial subcutaneous tumors in nude mice.
    Guichard M; Courdi A; Fertil B; Malaise EP
    Radiat Res; 1979 May; 78(2):278-85. PubMed ID: 451157
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
    Murata R; Tsujitani M; Horsman MR
    Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerator mass spectrometry allows for cellular quantification of doxorubicin at femtomolar concentrations.
    DeGregorio MW; Dingley KH; Wurz GT; Ubick E; Turteltaub KW
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):335-42. PubMed ID: 16047147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization of bleomycin on lethal effect of mouse cancer cell in vitro.
    Matsuzawa T; Onozawa M; Morita K; Kakehi M
    Strahlentherapie; 1972 Nov; 144(5):614-7. PubMed ID: 4119036
    [No Abstract]   [Full Text] [Related]  

  • 16. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice.
    Feleszko W; Mlynarczuk I; Balkowiec-Iskra EZ; Czajka A; Switaj T; Stoklosa T; Giermasz A; Jakóbisiak M
    Clin Cancer Res; 2000 May; 6(5):2044-52. PubMed ID: 10815931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEG-hemoglobin: effects on tumor oxygenation and response to chemotherapy.
    Teicher BA; Ara G; Herbst R; Takeuchi H; Keyes S; Northey D
    In Vivo; 1997; 11(4):301-11. PubMed ID: 9292296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motexafin gadolinium: a redox active drug that enhances the efficacy of bleomycin and doxorubicin.
    Miller RA; Woodburn KW; Fan Q; Lee I; Miles D; Duran G; Sikic B; Magda D
    Clin Cancer Res; 2001 Oct; 7(10):3215-21. PubMed ID: 11595717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dynamics of the immunodepressive and antitumor activity of adriamycin].
    Vereina TL; Turishchev VE; Gavrilova AD; Matveev AB
    Farmakol Toksikol; 1986; 49(1):73-5. PubMed ID: 3948992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.